Literature DB >> 20643191

Syntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression.

M A Cervinski1, J D Foster, R A Vaughan.   

Abstract

We investigated the functional relationship between the soluble N-ethylmaleimide-sensitive factor attachment receptor (SNARE) protein syntaxin 1A (syn 1A) and the dopamine transporter (DAT) by treating rat striatal tissue with Botulinum Neurotoxin C (BoNT/C) and co-transfecting syn 1A with DAT in non-neuronal cells, followed by analysis of DAT activity, phosphorylation, and regulation. Treatment of striatal slices with BoNT/C resulted in elevated dopamine (DA) transport Vmax and reduced DAT phosphorylation, while heterologous co-expression of syn 1A led to reduction in DAT surface expression and transport Vmax. Syn 1A was present in DAT immunoprecipitation complexes, supporting a direct or indirect interaction between the proteins. Phorbol ester regulation of DA transport activity was retained in BoNT/C-treated synaptosomes and syn 1A transfected cells, demonstrating that protein kinase C (PKC) and syn 1A effects occur through independent processes. These findings reveal a novel mechanism for regulation of DAT activity and phosphorylation, and suggest the potential for syn 1A to impact DA neurotransmission through effects on reuptake. Copyright 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  botulinum neurotoxin C; phorbol ester; synaptosomes; synprint domain; transport regulation

Mesh:

Substances:

Year:  2010        PMID: 20643191      PMCID: PMC2933327          DOI: 10.1016/j.neuroscience.2010.07.025

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  52 in total

Review 1.  The dopamine transporter proteome.

Authors:  Gonzalo E Torres
Journal:  J Neurochem       Date:  2006-04       Impact factor: 5.372

2.  Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms.

Authors:  Mark A Cervinski; James D Foster; Roxanne A Vaughan
Journal:  J Biol Chem       Date:  2005-10-04       Impact factor: 5.157

3.  Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation.

Authors:  Balachandra K Gorentla; Roxanne A Vaughan
Journal:  Neuropharmacology       Date:  2005-09-21       Impact factor: 5.250

Review 4.  Mechanisms of neurotransmitter release by amphetamines: a review.

Authors:  David Sulzer; Mark S Sonders; Nathan W Poulsen; Aurelio Galli
Journal:  Prog Neurobiol       Date:  2005-04       Impact factor: 11.685

Review 5.  Dopamine transporters and neuronal injury.

Authors:  G W Miller; R R Gainetdinov; A I Levey; M G Caron
Journal:  Trends Pharmacol Sci       Date:  1999-10       Impact factor: 14.819

6.  Affinity labeling the dopamine transporter ligand binding site.

Authors:  Roxanne A Vaughan; M Laura Parnas; Jon D Gaffaney; Margaret J Lowe; Sara Wirtz; Anh Pham; Brian Reed; Sucharita M Dutta; Kermit K Murray; Joseph B Justice
Journal:  J Neurosci Methods       Date:  2004-12-02       Impact factor: 2.390

Review 7.  Role of monoamine transporters in mediating psychostimulant effects.

Authors:  Evan L Riddle; Annette E Fleckenstein; Glen R Hanson
Journal:  AAPS J       Date:  2005-12-20       Impact factor: 4.009

8.  Mechanism of SNARE protein binding and regulation of Cav2 channels by phosphorylation of the synaptic protein interaction site.

Authors:  Charles T Yokoyama; Scott J Myers; Jian Fu; Susan M Mockus; Todd Scheuer; William A Catterall
Journal:  Mol Cell Neurosci       Date:  2005-01       Impact factor: 4.314

9.  Regulation of amphetamine-stimulated dopamine efflux by protein kinase C beta.

Authors:  L'Aurelle A Johnson; Bipasha Guptaroy; David Lund; Susanna Shamban; Margaret E Gnegy
Journal:  J Biol Chem       Date:  2005-01-12       Impact factor: 5.157

10.  Enhanced ubiquitylation and accelerated degradation of the dopamine transporter mediated by protein kinase C.

Authors:  Manuel Miranda; Christine C Wu; Tatiana Sorkina; Davin R Korstjens; Alexander Sorkin
Journal:  J Biol Chem       Date:  2005-08-18       Impact factor: 5.157

View more
  27 in total

1.  Palmitoylation by Multiple DHHC Enzymes Enhances Dopamine Transporter Function and Stability.

Authors:  Danielle E Bolland; Amy E Moritz; Daniel J Stanislowski; Roxanne A Vaughan; James D Foster
Journal:  ACS Chem Neurosci       Date:  2019-04-19       Impact factor: 4.418

2.  SKF-83566, a D1-dopamine receptor antagonist, inhibits the dopamine transporter.

Authors:  Melissa A Stouffer; Solav Ali; Maarten E A Reith; Jyoti C Patel; Federica Sarti; Kenneth D Carr; Margaret E Rice
Journal:  J Neurochem       Date:  2011-07-21       Impact factor: 5.372

3.  Dopamine transporter trafficking and Rit2 GTPase: Mechanism of action and in vivo impact.

Authors:  Rita R Fagan; Patrick J Kearney; Carolyn G Sweeney; Dino Luethi; Florianne E Schoot Uiterkamp; Klaus Schicker; Brian S Alejandro; Lauren C O'Connor; Harald H Sitte; Haley E Melikian
Journal:  J Biol Chem       Date:  2020-03-04       Impact factor: 5.157

4.  Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding.

Authors:  Amy E Moritz; James D Foster; Balachandra K Gorentla; Michelle S Mazei-Robison; Jae-Won Yang; Harald H Sitte; Randy D Blakely; Roxanne A Vaughan
Journal:  J Biol Chem       Date:  2012-11-16       Impact factor: 5.157

5.  Reciprocal Phosphorylation and Palmitoylation Control Dopamine Transporter Kinetics.

Authors:  Amy E Moritz; Danielle E Rastedt; Daniel J Stanislowski; Madhur Shetty; Margaret A Smith; Roxanne A Vaughan; James D Foster
Journal:  J Biol Chem       Date:  2015-09-30       Impact factor: 5.157

Review 6.  Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.

Authors:  Daniel P Bermingham; Randy D Blakely
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

Review 7.  Mechanisms of dopamine transporter regulation in normal and disease states.

Authors:  Roxanne A Vaughan; James D Foster
Journal:  Trends Pharmacol Sci       Date:  2013-08-20       Impact factor: 14.819

8.  PLRP2 selectively localizes synaptic membrane proteins via acyl-chain remodeling of phospholipids.

Authors:  Hideaki Kuge; Izumi Miyamoto; Ken-Ichi Yagyu; Koichi Honke
Journal:  J Lipid Res       Date:  2020-09-22       Impact factor: 5.922

Review 9.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 10.  SLC6 transporters: structure, function, regulation, disease association and therapeutics.

Authors:  Akula Bala Pramod; James Foster; Lucia Carvelli; L Keith Henry
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.